Check medicine papers: citations, claims and retractions

Respiratory Sinus Arrhythmia: A Phenomenon Improving Pulmonary Gas Exchange and Circulatory Efficiency

Hayano, J., Yasuma, F., Okada, A., Mukai, S., & Fujinami, T. (1996) · Circulation

Heart Rate Variability and Autonomic ControlNeuroscience of respiration and sleep

Cited by 332

Physical activity during school recess

Ridgers, N. D., Salmon, J., Parrish, A.-M., Stanley, R. M., & Okely, A. D. (2012) · American Journal of Preventive Medicine

Physical Activity and HealthObesity, Physical Activity, Diet

Cited by 332

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer

Chabanon, R. M., Muirhead, G., Krastev, D. B., Adam, J., Morel, D., Garrido, M., Lamb, A., Hénon, C., Dorvault, N., Rouanne, M., et al. (2019) · Journal of Clinical Investigation

PARP inhibition in cancer therapyinterferon and immune responses

Cited by 332

Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study

Leitner, Y., Fattal-Valevski, A., Geva, R., Eshel, R., Toledano-Alhadef, H., Rotstein, M., Bassan, H., Radianu, B., Bitchonsky, O., Jaffa, A. J., et al. (2007) · Journal of Child Neurology

Infant Development and Preterm CareBirth, Development, and Health

Cited by 332

Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity

Misra, A., Vikram, N. K., Gupta, R., Pandey, R. M., Wasir, J. S., & Gupta, V. P. (2006) · International Journal of Obesity

Diabetes, Cardiovascular Risks, and LipoproteinsBody Composition Measurement Techniques

Cited by 332

Deconstructing adipogenesis induced by β3-Adrenergic receptor activation with single-cell expression profiling

Burl, R. B., Ramseyer, V. D., Rondini, E. A., Pique-Regi, R., Lee, Y.-H., & Granneman, J. G. (2018) · Cell Metabolism

Adipose Tissue and MetabolismSingle-cell and spatial transcriptomics

Cited by 332

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices

Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012) · Psychological Medicine

Schizophrenia research and treatmentHealth Promotion and Cardiovascular Prevention

Cited by 332

Regulation of Pancreatic Insulin and Glucagon Secretion

Gerich, J. E., Charles, M. A., & Grodsky, G. M. (1976) · Annual Review of Physiology

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 332

Quantification of liver fat using magnetic resonance spectroscopy

Thomsen, C., Becker, U., Winkler, K., Christoffersen, P., Jensen, M., & Henriksen, O. (1994) · Magnetic Resonance Imaging

Liver Disease Diagnosis and TreatmentAdvanced MRI Techniques and Applications

Cited by 332

Cognitive function in nondemented older women who took estrogen after menopause

Jacobs, D. M., Tang, M.-X., Stern, Y., Sano, M., Marder, K., Bell, K. L., Schofield, P., Dooneief, G., Gurland, B., & Mayeux, R. (1998) · Neurology

Menopause: Health Impacts and TreatmentsDementia and Cognitive Impairment Research

Cited by 332

Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population

Morgan, J. R., Schackman, B. R., Leff, J. A., Linas, B. P., & Walley, A. Y. (2018) · Journal of Substance Abuse Treatment

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 332

A randomized pilot study comparing zero‐calorie alternate‐day fasting to daily caloric restriction in adults with obesity

Catenacci, V. A., Pan, Z., Ostendorf, D., Brannon, S., Gozansky, W. S., Mattson, M. P., Martin, B., MacLean, P. S., Melanson, E. L., & Troy Donahoo, W. (2016) · Obesity

Dietary Effects on HealthDiet and metabolism studies

Cited by 332

Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38

Escande, C., Nin, V., Price, N. L., Capellini, V., Gomes, A. P., Barbosa, M. T., O’Neil, L., White, T. A., Sinclair, D. A., & Chini, E. N. (2013) · Diabetes

Sirtuins and Resveratrol in MedicineNatural Antidiabetic Agents Studies

Cited by 332

Broad Consent for Research With Biological Samples: Workshop Conclusions

Grady, C., Eckstein, L., Berkman, B., Brock, D., Cook-Deegan, R., Fullerton, S. M., Greely, H., Hansson, M. G., Hull, S., Kim, S., et al. (2015) · The American Journal of Bioethics

Ethics in Clinical ResearchEthics and bioethics in healthcare

Cited by 332

FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine

Warraich, H. J., Tazbaz, T., & Califf, R. M. (2025) · JAMA

Artificial Intelligence in Healthcare and EducationHealthcare Regulation

Cited by 332

Assessing health system performance in developing countries: A review of the literature

Kruk, M. E., & Freedman, L. P. (2008) · Health Policy

Healthcare Systems and ReformsHealthcare Systems and Practices

Cited by 332

Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial

Morrison, A. P., French, P., Stewart, S. L. K., Birchwood, M., Fowler, D., Gumley, A. I., Jones, P. B., Bentall, R. P., Lewis, S. W., Murray, G. K., et al. (2012) · BMJ

Schizophrenia research and treatmentPsychotherapy Techniques and Applications

Cited by 332

Copper resistance is essential for virulence of Mycobacterium tuberculosis

Wolschendorf, F., Ackart, D., Shrestha, T. B., Hascall-Dove, L., Nolan, S., Lamichhane, G., Wang, Y., Bossmann, S. H., Basaraba, R. J., & Niederweis, M. (2011) · Proceedings of the National Academy of Sciences

Tuberculosis Research and EpidemiologyTrace Elements in Health

Cited by 332

Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts

Makarenko, I., Opitz, C. A., Leake, M. C., Neagoe, C., Kulke, M., Gwathmey, J. K., del Monte, F., Hajjar, R. J., & Linke, W. A. (2004) · Circulation Research

Cardiomyopathy and Myosin StudiesCardiac Fibrosis and Remodeling

Cited by 332

Letter to the Editor: obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

Zheng, K. I., Gao, F., Wang, X.-B., Sun, Q.-F., Pan, K.-H., Wang, T.-Y., Ma, H.-L., Chen, Y.-P., Liu, W.-Y., George, J., et al. (2020) · Metabolism

COVID-19 Clinical Research StudiesLiver Disease Diagnosis and Treatment

Cited by 332

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 332

Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects

Clarke, K., Tchabanenko, K., Pawlosky, R., Carter, E., Todd King, M., Musa-Veloso, K., Ho, M., Roberts, A., Robertson, J., VanItallie, T. B., et al. (2012) · Regulatory Toxicology and Pharmacology

Diet and metabolism studiesDietary Effects on Health

Cited by 332

Association between initial opioid prescribing patterns and subsequent long-term use among opioid-naïve patients: a statewide retrospective cohort study

Deyo, R. A., Hallvik, S. E., Hildebran, C., Marino, M., Dexter, E., Irvine, J. M., O’Kane, N., Van Otterloo, J., Wright, D. A., Leichtling, G., et al. (2017) · Journal of General Internal Medicine

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 332

What is the pipeline for future medications for obesity?

Melson, E., Ashraf, U., Papamargaritis, D., & Davies, M. J. (2025) · International Journal of Obesity

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 332